Written and maintained by CASRAI Editorial Board
Last updated
The Merit-based Incentive Payment System (MIPS) is the foundational fee-for-service value-based performance program within the Quality Payment Program (QPP) administered by the Centers for Medicare & Medicaid Services (CMS). Enacted by Congress under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA, Public Law 114-10) and codified at 42 CFR Part 414, Subpart O, MACRA repealed the Medicare Sustainable Growth Rate (SGR) formula and consolidated three legacy Medicare reporting programs—the Physician Quality Reporting System (PQRS), the Physician Value-Based Payment Modifier (VM), and the Medicare EHR Incentive Program for Eligible Professionals—into a single composite scoring framework.
Under MIPS, CMS evaluates participating Medicare Part B clinicians across four weighted performance categories—Quality, Cost, Promoting Interoperability (PI), and Improvement Activities (IA)—over a calendar-year performance period to compute a MIPS Final Score (0 to 100 points). That composite score is compared against a national performance threshold to apply positive, neutral, or negative payment adjustments (up to ±9%) to Medicare Part B covered professional services two years later (Payment Year = Performance Year + 2). Alongside ambulatory reimbursement governance, MIPS drives clinical informatics standardization through ONC Certified Health IT Product List (CHPL) requirements and specialty outcomes research via Qualified Clinical Data Registries (QCDRs).
MACRA Quality Payment Program Architecture: MIPS vs. Advanced APMs
The MACRA Quality Payment Program divides clinician participation into two statutory tracks:
- Merit-based Incentive Payment System (MIPS): Evaluates individual clinicians, medical groups, virtual groups, and APM Entities on a 0-to-100 point scale across Quality, Cost, Promoting Interoperability, and Improvement Activities, adjusting subsequent Medicare Part B professional fee payments routed via CMS-1500 (837P) claims.
- Advanced Alternative Payment Models (Advanced APMs): Evaluates participation in CMS innovation models or Statutory APMs that meet three criteria under 42 CFR § 414.1415: (a) require at least 75% of eligible clinicians to use Certified Electronic Health Record Technology (CEHRT), (b) tie payment to quality measures comparable to MIPS, and (c) require entities to bear more than nominal financial downside risk. Clinicians who meet statutory Medicare payment or patient count thresholds become Qualifying APM Participants (QPs) and are exempt from MIPS reporting.
MIPS Eligible Clinician Types and Low-Volume Thresholds
MIPS applies to specific Medicare Part B clinician categories, including physicians (MD, DO, dental medicine, podiatry, optometry, chiropractors), physician assistants (PAs), nurse practitioners (NPs), clinical nurse specialists (CNSs), certified registered nurse anesthetists (CRNAs), physical and occupational therapists, speech-language pathologists, audiologists, clinical psychologists, registered dietitians, and certified nurse-midwives. Clinicians are excluded from mandatory MIPS reporting if they are newly enrolled in Medicare for the first time during the performance year, achieve QP status, or fall below the Low-Volume Threshold (LVT) across all three criteria during the two-segment determination period:
- Allowed Charges: Less than or equal to $90,000 in Medicare Part B covered professional services;
- Beneficiary Count: 200 or fewer Medicare Part B beneficiaries receiving covered professional services; or
- Covered Professional Services: 200 or fewer covered professional services furnished to Medicare Part B beneficiaries.
Clinicians or groups exceeding one or two (but not all three) low-volume criteria may elect to opt-in to receive a MIPS payment adjustment or voluntarily report for feedback without payment adjustment exposure.
The Four MIPS Performance Categories and Standard Weights
Under statutory weighting established by MACRA (42 CFR § 414.1380), the MIPS Final Score (0 to 100 points) sums weighted points from four performance categories:
| Performance Category | Standard Weight | Minimum Performance Period | Data Submission Mechanism | Core Assessment Focus |
|---|---|---|---|---|
| Quality | 30% | Full calendar year (365 days; Jan 1 – Dec 31) | eCQM, MIPS CQM, QCDR Measures, Medicare Part B Claims (small practices), or CAHPS for MIPS Survey | Clinical processes, patient-reported outcomes, intermediate outcomes, and administrative claims readmission/complication rates |
| Cost | 30% | Full calendar year (365 days; Jan 1 – Dec 31) | Calculated automatically by CMS from Medicare Part A and Part B administrative claims (no clinician submission) | Risk-adjusted resource utilization across Total Per Capita Cost (TPCC), MSPB Clinician, and episode-based cost measures |
| Promoting Interoperability (PI) | 25% | Minimum continuous 180-day period within the calendar year | Direct attestation, EHR QRDA III, or third-party registry submission using ONC-certified CEHRT | e-Prescribing, Health Information Exchange (HIE/TEFCA), Provider-to-Patient FHIR API access, and Public Health Registry reporting |
| Improvement Activities (IA) | 15% | Minimum continuous 90-day period within the calendar year | Yes/No attestation via QPP portal, EHR, Qualified Registry, or QCDR | Care coordination, patient safety, health equity, behavioral health integration, and clinical trial/registry participation |
1. Quality Performance Category (30% Weight)
In traditional MIPS, clinicians or groups must generally report at least 6 quality measures for the full 12-month calendar year, including at least one Outcome Measure (or another High-Priority Measure—such as appropriate use, patient safety, efficiency, patient experience, or care coordination—if no applicable outcome measure exists). In addition to clinician-submitted measures, CMS automatically calculates population-based administrative claims measures (such as the Hospital-Wide All-Cause Unplanned Readmission [HWR] measure and the Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions) for groups meeting minimum case-size thresholds.
Each submitted quality measure must satisfy the Data Completeness Requirement (reporting performance or exclusion data on at least 75% of eligible instances across all payers for eCQMs, MIPS CQMs, and QCDR measures) and have a minimum case size of 20 eligible cases to be scored against national decile benchmarks (earning 1 to 10 achievement points per measure).
2. Cost Performance Category (30% Weight)
Clinicians submit no separate data for the Cost category. CMS computes cost performance directly from Medicare Part A and Part B administrative claims using hierarchical condition category (CMS-HCC risk adjustment) and specialty-adjustment models across three measure groups:
- Total Per Capita Cost (TPCC): Assesses overall risk-adjusted Medicare Part A and Part B spending for beneficiaries attributed to primary care relationships (minimum 20 attributed beneficiaries).
- Medicare Spending Per Beneficiary (MSPB) Clinician: Evaluates risk-adjusted Medicare spending across an inpatient hospitalization episode spanning from 3 days prior to admission through 30 days post-discharge (minimum 35 episodes).
- Episode-Based Cost Measures: Procedural, acute inpatient medical condition, and chronic condition episode measures (such as elective outpatient percutaneous coronary intervention, knee arthroplasty, diabetes, or heart failure) attributed to clinicians managing at least 20 episodes (or 10 episodes for procedural measures).
3. Promoting Interoperability (PI) Category (25% Weight)
Paralleling the inpatient Promoting Interoperability Program for Hospitals, the MIPS Promoting Interoperability category requires eligible clinicians to use EHR systems certified to the ONC Certification Criteria (verified via a 15-character CMS EHR Certification ID from the ONC CHPL) over a continuous 180-day minimum period. Clinicians must complete mandatory attestations—including conducting an annual HIPAA Security Risk Analysis (45 CFR § 164.308(a)(1)(ii)(A)), SAFER Guides self-assessment, and ONC Direct Review / information-blocking compliance attestations—and report numerator/denominator data or exclusions across four objectives:
- e-Prescribing: Electronic prescribing of permissible prescriptions and querying a Prescription Drug Monitoring Program (PDMP) for Schedule II, III, and IV controlled substances.
- Health Information Exchange (HIE): Supporting electronic referral loops via C-CDA exchange, bi-directional HIE network participation, or participation as a signatory to a Framework Agreement under the Trusted Exchange Framework and Common Agreement (TEFCA).
- Provider to Patient Exchange: Providing patients timely electronic access to their USCDI clinical health information via standards-based HL7 FHIR APIs.
- Public Health and Clinical Data Exchange: Active engagement with immunization registries and electronic case reporting (eCR), with optional bonus points for syndromic surveillance, public health registry, or clinical data registry reporting.
Certain clinician types—such as hospital-based clinicians (furnishing ≥75% of covered professional services in POS 21, 22, or 23), non-patient-facing clinicians, ambulatory surgical center (ASC)-based clinicians, and small practices (15 or fewer clinicians)—qualify for automatic reweighting of the 25% Promoting Interoperability weight to the Quality and Improvement Activities categories unless they voluntarily submit PI data.
4. Improvement Activities (IA) Category (15% Weight)
The Improvement Activities category rewards clinical practice improvements performed over at least a continuous 90-day period. CMS maintains an inventory of more than 100 clinical practice activities spanning patient safety, care coordination, beneficiary engagement, emergency preparedness, and participation in clinical trials or QCDRs. In group reporting, at least 50% of the group’s NPIs under the Taxpayer Identification Number (TIN) must perform the same activity during any continuous 90-day period within the performance year.
MIPS Value Pathways (MVPs) and Subgroup Reporting
To reduce reporting burden and eliminate cherry-picking from unrelated quality measures, CMS introduced MIPS Value Pathways (MVPs) under 42 CFR § 414.1365. Each MVP is a specialty- or condition-specific framework (such as Advancing Rheumatology Patient Care, Optimal Care for Patients with Episodic Neurological Conditions, or Value in Primary Care) that links a curated subset of quality measures, improvement activities, and cost measures around a unified clinical theme.
- MVP Selection Requirements: An MVP participant selects 4 quality measures (rather than 6 in traditional MIPS), including at least one outcome or high-priority measure, plus improvement activities from the MVP’s curated menu, while CMS calculates the MVP-specific cost measures and the foundational layer (Promoting Interoperability and population health administrative claims measures).
- Multispecialty Subgroup Reporting: MVPs enable large multispecialty TINs to partition clinicians into specialty-specific Subgroups so that cardiologists, oncologists, and surgical specialists within an academic medical center can be evaluated on specialty-relevant measures rather than a single TIN-wide aggregate score.
Qualified Clinical Data Registries (QCDRs) in Clinical Research
Under 42 CFR § 414.1400, a Qualified Clinical Data Registry (QCDR) is a CMS-approved entity (often operated by a medical specialty society, academic research consortium, or regional quality collaborative) that collects clinical data from multiple payers (both Medicare and non-Medicare patients) to foster quality improvement and observational outcomes research. Unlike standard Qualified Registries—which can only report standard MIPS CQMs—a QCDR may develop, validate, and gain CMS approval for up to 30 custom non-MIPS QCDR measures grounded in specialty clinical practice guidelines and peer-reviewed evidence. This architecture allows academic departments and multi-site clinical research networks to align longitudinal disease registries with regulatory MACRA reporting.
Frequently Asked Questions
What is the Merit-based Incentive Payment System (MIPS)?
The Merit-based Incentive Payment System (MIPS) is the primary value-based performance track of the Quality Payment Program (QPP) administered by the Centers for Medicare & Medicaid Services (CMS) under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA, Public Law 114-10, 42 CFR Part 414 Subpart O). MIPS evaluates eligible Medicare Part B clinicians across four weighted categories—Quality (30%), Cost (30%), Promoting Interoperability (25%), and Improvement Activities (15%)—to calculate a 0-to-100 composite final score that determines positive, neutral, or negative Medicare Part B payment adjustments up to ±9% two years after the performance period.
How is the Merit-based Incentive Payment System used in clinical research and healthcare?
In clinical care and outcomes research, MIPS standardizes ambulatory quality measurement using electronic Clinical Quality Measures (eCQMs) extracted via HL7 QRDA/FHIR and supports observational registry research through CMS-approved Qualified Clinical Data Registries (QCDRs). Specialty societies and academic research networks operate QCDRs to collect both standard MIPS measures and custom, evidence-based non-MIPS QCDR measures across multi-payer longitudinal cohorts.
How does MIPS differ from Advanced Alternative Payment Models (APMs) under MACRA?
MACRA established two tracks within the Quality Payment Program: MIPS and Advanced Alternative Payment Models (Advanced APMs). While MIPS adjusts fee-for-service Medicare Part B professional claims based on a 0-to-100 composite performance score, clinicians who achieve Qualifying APM Participant (QP) thresholds in an Advanced APM—which requires use of ONC-certified EHR technology, quality measurement comparable to MIPS, and bearing more than nominal two-sided financial risk—are excluded from MIPS reporting and payment adjustments.
